<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
      <restricted-by>pmc</restricted-by>
    </processing-meta>
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">J Manag Care Spec Pharm</journal-id>
        <journal-id journal-id-type="iso-abbrev">J Manag Care Spec Pharm</journal-id>
        <journal-id journal-id-type="publisher-id">jmcsp</journal-id>
        <journal-title-group>
          <journal-title>Journal of Managed Care &amp; Specialty Pharmacy</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">2376-0540</issn>
        <issn pub-type="epub">2376-1032</issn>
        <publisher>
          <publisher-name>Academy of Managed Care Pharmacy</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmid">35332789</article-id>
        <article-id pub-id-type="pmc">10373001</article-id>
        <article-id pub-id-type="doi">10.18553/jmcp.2022.28.4.461</article-id>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Research</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name>
              <surname>Hinahara</surname>
              <given-names>Jordan</given-names>
            </name>
            <degrees>BA</degrees>
            <xref rid="aff1" ref-type="aff">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Weinzimer</surname>
              <given-names>Stuart A</given-names>
            </name>
            <degrees>MD</degrees>
            <xref rid="aff2" ref-type="aff">
              <sup>2</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Bromley</surname>
              <given-names>Emilie R</given-names>
            </name>
            <degrees>MPH</degrees>
            <xref rid="aff1" ref-type="aff">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Goss</surname>
              <given-names>Thomas F</given-names>
            </name>
            <degrees>PharmD</degrees>
            <xref rid="aff1" ref-type="aff">
              <sup>1</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author">
            <name>
              <surname>Kendall</surname>
              <given-names>David M</given-names>
            </name>
            <degrees>MD</degrees>
            <xref rid="aff3" ref-type="aff">
              <sup>3</sup>
            </xref>
          </contrib>
          <contrib contrib-type="author" corresp="yes">
            <name>
              <surname>Hammer</surname>
              <given-names>Mette</given-names>
            </name>
            <degrees>MSc</degrees>
            <xref rid="aff3" ref-type="aff">
              <sup>3</sup>
            </xref>
            <xref rid="cor1" ref-type="corresp">
              <sup>*</sup>
            </xref>
          </contrib>
          <aff id="aff1"><label>1</label>Boston Healthcare Associates, Boston, MA.</aff>
          <aff id="aff2"><label>2</label>Yale University School of Medicine, New Haven, CT.</aff>
          <aff id="aff3"><label>3</label>Zealand Pharma A/S, Copenhagen, Denmark.</aff>
        </contrib-group>
        <author-notes>
          <corresp id="cor1"><label>*</label>AUTHOR CORRESPONDENCE: Mette Hammer, +45.5060.3887; <email>mhammer@zealandpharma.com</email></corresp>
          <fn fn-type="COI-statement">
            <p>This research was funded by Zealand Pharma. Bromley, Hinahara, and Goss are employed by Boston Healthcare Associates, Inc., which received funding from Zealand Pharma for development of the health economic model and the manuscript. Kendall and Hammer are employed by Zealand Pharma. Weinzimer has received consulting fees from Zealand Pharma.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <month>4</month>
          <year>2022</year>
        </pub-date>
        <volume>28</volume>
        <issue>4</issue>
        <elocation-id>10.18553/jmcp.2022.28.4.461</elocation-id>
        <permissions>
          <copyright-statement>Copyright Â© 2022, Academy of Managed Care Pharmacy. All rights reserved.</copyright-statement>
          <copyright-year>2022</copyright-year>
          <!--Edit 1 -->
        </permissions>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
